Literature DB >> 35991768

Treating hepatitis C during the COVID-19 pandemic in Alberta.

Samuel S Lee1,2, Sarah A Williams1, Jacqueline Pinto1, Heidi Israelson1, Hongqun Liu2.   

Abstract

Entities:  

Year:  2021        PMID： 35991768      PMCID： PMC9204936          DOI： 10.3138/canlivj-2021-0007

Source DB:  PubMed          Journal:  Can Liver J        ISSN： 2561-4444


× No keyword cloud information.
  3 in total

1.  Outcomes of treatment for hepatitis C virus infection by primary care providers.

Authors:  Sanjeev Arora; Karla Thornton; Glen Murata; Paulina Deming; Summers Kalishman; Denise Dion; Brooke Parish; Thomas Burke; Wesley Pak; Jeffrey Dunkelberg; Martin Kistin; John Brown; Steven Jenkusky; Miriam Komaromy; Clifford Qualls
Journal:  N Engl J Med       Date:  2011-06-01       Impact factor: 91.245

2.  Real-world treatment of hepatitis C with second-generation direct-acting antivirals: initial results from a multicentre Canadian retrospective cohort of diverse patients.

Authors:  Alex I Aspinall; Abdel A Shaheen; Golasa S Kochaksaraei; Breean Haslam; Samuel S Lee; Gisela Macphail; Jeff Kapler; Oscar E Larios; Kelly W Burak; Mark G Swain; Meredith A Borman; Carla S Coffin
Journal:  CMAJ Open       Date:  2018-01-05

Review 3.  Revolution in hepatitis C antiviral therapy.

Authors:  Matthew D Sadler; Samuel S Lee
Journal:  Br Med Bull       Date:  2015-02-13       Impact factor: 4.291
  3 in total
  1 in total

1.  ECHO+: Improving access to hepatitis C care within Indigenous communities in Alberta, Canada.

Authors:  Kate Pr Dunn; Kienan P Williams; Cari E Egan; Melissa L Potestio; Samuel S Lee
Journal:  Can Liver J       Date:  2022-05-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.